Fibroblast Growth Factor Receptor Inhibition for Cholangiocarcinoma: Looking Through a Door Half-Opened

Hepatology. 2018 Dec;68(6):2428-2430. doi: 10.1002/hep.30069. Epub 2018 Nov 7.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Adult
  • Bile Duct Neoplasms*
  • Bile Ducts, Intrahepatic*
  • Cholangiocarcinoma*
  • Humans
  • Phenylurea Compounds
  • Pyrimidines
  • Receptors, Fibroblast Growth Factor / antagonists & inhibitors

Substances

  • Phenylurea Compounds
  • Pyrimidines
  • Receptors, Fibroblast Growth Factor
  • infigratinib